Background {#Sec1}
==========

Critically ill patients experience various discomforts during their intensive care unit (ICU) stay. These discomforts may traditionally be distinguished as discomforts related to the environment (noise, light, temperature, etc.), discomforts related to some aspects of care organization (continuous monitoring, limited visiting hours, privacy not guaranteed, etc.), and discomforts related to specific ICU therapeutics such as mechanical ventilation (MV), noninvasive ventilation (NIV), renal replacement therapy (RRT), or painful procedures \[[@CR1]\]. Recognizing these sources of discomfort in the ICU is a first step for optimizing patient comfort in the ICU through a tailored program aimed to identify and quantify discomfort sources, understand reasons for them, initiate care strategies to prevent, remove or reduce them, and assess potential improvements due to such programs in the health status of survivors of critical illness after an ICU stay.

Detection of discomforts may be performed using objective measures characterizing some stressors, such noise or excess lighting, or by measuring the impact of these stressors on physiologic parameters, or through subjective measures, including patient-reported measures. Patient-reported outcomes are now recognized as a satisfactory picture of patient perceptions that has led to the development of specific ICU-related perceived discomfort tools. From the available tools \[[@CR2], [@CR3]\], the 'Inconforts des Patients de REAnimation (IPREA)' questionnaire \[[@CR4]\], as a self-perceived ICU discomfort measure, is differentiated by a validation process based on international guidelines, performed using a large sample of patients managed in various types of ICUs (medical and surgical). The IPREA questionnaire is a 16-item self-administered questionnaire with satisfactory psychometric properties and good acceptability that makes it relevant for implementation in routine clinical practice. According to the item selection step, some discomforts were not retained in the final version of the questionnaire. The clinical use of IPREA and an update of the literature review \[[@CR5], [@CR6]\] highlighted the recurrent dissatisfaction of both ICU healthcare workers and ICU patients with two main missing items, concerning ICU-related mood disorders and ICU-related breathing discomfort: feeling depressed and shortness of breath occurring during the ICU stay.

Dyspnea is prevalent in mechanically ventilated patients \[[@CR7]\] but also in patients experiencing VNI \[[@CR8]\]. Often underestimated by caregivers, dyspnea or shortness of breath as perceived by the ICU patients may expose them to anxiety and fear and consequently complicate care. Authors have previously emphasized the need for further development and standardization of methods to assess dyspnea in ICU patients \[[@CR9]\].

Survivors of critical illness have high rates of depression and post-traumatic stress disorder, and depression has been found to be independently associated with an increased risk for rehospitalization \[[@CR10]--[@CR12]\]. Few studies have explored the phenomenon specifically during the ICU stay, although the clinically apparent symptoms of depression and anxiety are often present before the ICU discharge and commonly acknowledged by health care workers and caregivers \[[@CR13]\]. The presence of these symptoms during the ICU stay has also been shown to be one of the strongest risk factors for poor psychological outcomes after critical care. Based on these findings, international health agencies \[[@CR14]\] announced that patients should be assessed during their critical care stay for detecting and recognizing psychological stress using practical routine clinical tools \[[@CR15]\].

The IPREA study group also proposed adding two items to the initial version of the IPREA questionnaire, leading to an 18-item version. We reported the metric validity of the 18-item version of the IPREA questionnaire including 2 new items exploring ICU-related feelings of depression and ICU-related breathing discomfort.

Methods {#Sec2}
=======

Sample and design {#Sec3}
-----------------

The participants of this validation step were patients included in a multicenter, cluster-randomized, controlled, two-parallel group study built to assess the effectiveness of a tailored multicomponent program (TMCP) for reducing self-perceived discomfort in the ICU, previously detailed \[[@CR16], [@CR17]\]. In this study, 34 French ICUs, that were medical, surgical, or mixed medical-surgical ICUs located at academic tertiary care hospitals or community hospitals, were randomized to either an experimental arm during which the TMCP (identification of discomforts, immediate feedback to the healthcare team, and implementation of targeted interventions) was implemented or to a control arm during which any program was implemented. The TMCP (described elsewhere \[[@CR16], [@CR17]\]) targeting all members of the healthcare team consisted of discomfort assessment with IPREA, immediate feedback to bedside nurses and monthly feedback to the healthcare team, and tailored site-targeted interventions. For the validation of the 18-item version of IPREA, only patients admitted to the ICU in which any program was implemented (Fig. [1](#Fig1){ref-type="fig"}) were eligible.Fig. 1Chart

All patients aged 18 years or older who survived an ICU stay of 3 calendar days or more were eligible for inclusion. We excluded patients who died during the ICU stay, patients under trusteeship, patients with diminished mental capacity (patients with delirium were excluded), patients who did not understand French sufficiently to be questioned, and patients transferred to another ICU while mechanically ventilated.

Ethics, consent and permissions {#Sec4}
-------------------------------

Regulatory monitoring was performed in accordance with the French law requiring the approval of the French ethics committee (Comité de Protection des Personnes Tours Région Centre-Ouest 1, 28/08/2013, reference number 2013-S10). All records and subject' identities remained confidential in accordance with French regulations: the French National Committee of Informatics and Liberties (Commission nationale de l'informatique et des libertés, 20/03/2014, reference number DR-2014-097) and the French Consultative Committee for the data processing in health research (Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé, 12/12/2013, reference number 13.642bis). Consent was obtained from each participant.

Procedure and data collection {#Sec5}
-----------------------------

Each participating ICU was supplied with tablets with Internet connection. On the day of ICU discharge, if the patient presented eligibility criteria and had no exclusion criteria, the bedside nurse was to administer the self-perceived ICU discomfort questionnaire. To ensure adequate training of the nursing staff, the application had been in use in each ICU for a training period with technical and educational support provided by the coordination team.

Data related to the patient were recorded from an electronic case report form. The following data were collected: demographics (sex, age), type of admission (medical, scheduled surgical, and emergency surgical), health status before the ICU stay using the Knaus score and the McCabe index, health status at ICU admission using the Simplified Acute Physiology Score (SAPS II), health status from the ICU admission to ICU discharge (mechanical ventilation, noninvasive ventilation, administration of vasopressors, and renal replacement therapy), and duration of ICU stay.

The patients' discomfort was assessed using the French self-reported discomfort IPREA questionnaire ('Inconforts des Patients de REAnimation', Discomforts perceived by ICU patients), including 18 discomfort-items: noise, excess of light, discomfort related to sleeping in a different bed from home, sleep deprivation, thirst, hunger, feeling of cold, feeling of heat, pain, being tied down by perfusion lines, tubes or other connected monitoring devices, no respect for privacy, anxiety, isolation, limited visiting hours, absence of phone, lack of information, shortness of breath, and felling depressed. Each item was scored from 0 (minimal discomfort) to 10 (maximal discomfort), yielding 18 linearized scores and an overall score of discomfort scored from 0 (minimal discomfort) to 100 (maximal discomfort). The questionnaire was administered on the day of ICU discharge. The timeframe considered the period from date of admission to the ICU until the day of discharge from the ICU.

Statistical analysis {#Sec6}
--------------------

The dimensional structure of the 18-item questionnaire was performed using a confirmatory factor analysis (CFA) using the Mplus software package \[[@CR18]\]. The fit to the model was tested by computing the root mean square error of approximation (RMSEA) and comparative fit index (CFI). RMSEA is acceptable if \< 0.08 and satisfactory if \< 0.05, and CFI is acceptable if \> 0.9 \[[@CR19], [@CR20]\]. Means and standard deviations were reported for each item. Floor and ceiling effects were reported assessing the homogeneous repartition of the response distribution. For each dimension, internal consistency reliability was assessed using Cronbach's alpha coefficient. A Cronbach's alpha coefficient of at least 0.7 was expected for each scale \[[@CR21], [@CR22]\]. The unidimensionality of each scale was assessed using Rasch analyses: item goodness-of-fit statistics (INFIT) and coefficient of Loevinger (H). INFIT statistics ranging between 0.7 and 1.2 and an H coefficient of at least 0.40 ensure that all the items of the scale tend to measure the same concept \[[@CR23]\]. Uniform and non-uniform differential item functioning (DIF) analyses following Crane's procedure \[[@CR24]\] were performed to compare the differences in item difficulties between groups (sex, Knaus score, and the McCabe index). The discriminant validity was determined by assessing the associations between the IPREA scores and sociodemographic and clinical features. For qualitative variables, the mean dimension scores of the IPREA were compared across patient groups that were expected to differ (e.g., sex, Knaus chronic health status \[[@CR25]\], MacCabe classification \[[@CR26]\], type of admission, MV, NIV, use of vasopressors, and RRT) using Student's t test. Quantitative variables (e.g., age, SAPS II, duration of ICU stay) were analyzed using Pearson's correlation coefficients. The underlying assumptions were derived from the initial validation of IPREA \[[@CR4]\]: women should report higher perceived discomforts than men, older patients should report lower discomforts, more severe patients (SAPS II) should report higher discomforts, and a patient's ICU-stay duration should be correlated to discomfort levels. For informational purpose, the same procedure was replicated on the 16 items included in the first validation \[[@CR4]\]. Data analyses were performed using R software and Stata 9.0. software.

Results {#Sec7}
=======

Sample characteristics {#Sec8}
----------------------

From the 34 French ICUs, 2447 patients were eligible, and the study sample included 994 patients resulting to a ratio of included/eligible patients of 41%. Because of incomplete questionnaires, 23 patients were not included in the analysis. Reasons for non-inclusion were detailed. All the details are provided in Fig. [1](#Fig1){ref-type="fig"}. Key clinical and demographic characteristics are provided in Table [1](#Tab1){ref-type="table"}.Table 1Sample characteristics*N* = 994At admissionN (%) SexMen643 (64.7)Women351 (35.3) Age (years)M (SD)63.2 (15.6) Type of patientsMedical486 (48.9)Scheduled surgical308 (31.0)Emergency surgical200 (20.1) Knaus scoreNormal health status228 (22.9)Moderate/severe limitation766 (77.1) MacCabe scoreNon-fatal disease597 (60.1)Ultimately/rapidly fatal disease397 (39.9) SAPS IIM (SD)\
m \[IQR\]35.6 (16.6)\
33 \[23--46\]During ICU stay Mechanical ventilation531 (53.4) Noninvasive ventilation333 (33.5) Vasopressors administration388 (39.0) Renal replacement therapy85 (8.6) ICU stay duration (days)M (SD)\
m \[IQR\]7,8 (9,6)\
5 \[3--8\]*M (SD)* Mean (standard deviation), *m \[IQR\]* Median \[interquartile range\]SAPS II Simplified Acute Physiology Score II (range from 0 to 156, with higher scores indicating more severe illness)

Construct validity and internal structural validity {#Sec9}
---------------------------------------------------

The structure was confirmed using CFA, which showed a satisfactory fit (RMSEA at 0.042, CFI at 0.912). No multidimensional structure was identified, allowing the calculation of an overall score. The component factor analysis is illustrated in Fig. [2](#Fig2){ref-type="fig"}. The three highest discomforts were sleep deprivation, thirst, and perfusion lines/devices, and the 3 lowest discomforts were limited visiting hours, hunger, and isolation.Fig. 2Confirmatory factor analysis

Ceiling effects were considered satisfactory (lower than 10%), but floor effects were high for all the items. Internal consistency was satisfactory (Cronbach's alpha: 0.80). Eight dimensions showed a satisfactory scalability. All the items showed an INFIT statistics inside the acceptable ranges. All results are provided in Table [2](#Tab2){ref-type="table"}. Data from the 16-item version are provided in Table [2](#Tab2){ref-type="table"} as informative findings.Table 2Dimensions' characteristics of the 18-item IPREAItemLabelM ± SD ^a^Floor effect %Ceiling effect %Cronbach's alphaINFIT18i version18i version18i version*16i version*18i version*16i version*1Noise29.58 ± 31.7340.644.330.784*0.757*0.96*0.93*2Excess of light18.91 ± 27.9358.252.310.785*0.759*0.95*0.92*3Different bed24.81 ± 30.7548.693.720.790*0.765*1.04*1.02*4Sleep deprivation38.5 ± 33.9732.85.630.782*0.755*0.92*0.9*5Thirst31 ± 35.0445.677.240.794*0.773*1.14*1.15*6Hunger13.54 ± 2671.332.620.792*0.769*1.05*1.05*7Feeling of cold18.88 ± 28.3460.362.310.796*0.773*1.16*1.14*8Feeling of heat14.29 ± 26.5970.321.910.790*0.767*1.03*1.04*9Pain29.75 ± 29.4936.222.310.790*0.767*1.05*1.05*10Perf. lines/devices33.36 ± 31.7534.614.430.785*0.761*0.98*0.98*11Intimacy14.15 ± 24.9566.61.710.787*0.761*0.94*0.93*12Anxiety27.05 ± 31.6646.783.820.782*0.760*0.92*0.97*13Isolation13.19 ± 24.268.911.210.784*0.759*0.88*0.89*14Visiting hours9.64 ± 21.7177.771.410.793*0.770*1.03*1.02*15Phone14.1 ± 28.3773.744.020.794*0.771*1.12*1.11*16Information20.05 ± 28.7457.042.410.788*0.764*1.01*1.01*17Breathing28.42 ± 30.9442.253.720.7931.118Mood disorders14.36 ± 25.7368.211.910.7810.85*16-item total0.7761.01*18-item total^a^21.87 ± 13.751.100.7981.01M ± SD mean ± standard deviation; m (IQR) median (interquartile range); INFIT Rasch statistics^a^scores ranging from 0 to 100; the higher the score, the higher the discomfortItalic values: results of 16-item IPREA on the present sample

External validity {#Sec10}
-----------------

The overall discomfort score of the 18-item version of IPREA did not differ between men and women. Higher age was significantly correlated with a lower discomfort score. The overall score did not differ according to Knaus and MacCabe classification. Surgical patients reported lower overall discomfort scores than did medical patients. Patients with higher SAPS II reported higher overall discomfort scores. While MV was not linked to the overall discomfort score, patients treated by NIV reported higher overall discomfort scores than patients not treated by NIV. The ICU-stay duration was positively correlated to the overall discomfort score. All details are provided in Table [3](#Tab3){ref-type="table"}.Table 3Comparisons and correlations of IPREA scores with respect to patients' characteristics18 items\**p*-value16 items\*p-valueM (SD) / RM (SD) / RSexMen21.4 (13.6)0.1821.5 (13.,7)0.355Women22.6 (13.9)22.5 (14.1)Age\<=65 years22.9 (14.1)0.01723.1 (14.3)0.007\>  65 years20.8 (13.3)20.7 (13.4)Knaus scoreNormal22.9 (14.3)0.19223.3 (14.4)0.090Moderate/severe21.6 (13.6)21.5 (13.7)MacCabeNon fatal disease22.5 (14.1)0.08022.6 (14.2)0.045Fatal disease20.9 (13.2)20.8 (13.4)Type of admissionMedical23.5 (14.6)0.00123.4 (14.7)0.006Surgical20.2 (12.6)20.5 (12.8)SAPS II0.0990.0020.0880.006Mechanical ventilationNo21.6 (14.0)0.41721.6 (14.1)0.416Yes22.0 (13.5)22.1 (13.7)Non mechanical ventilationNo21.1 (13.4)0.03221.3 (13.6)0.115Yes23.3 (14.1)23.0 (14.2)Vasopressors administrationNo21.7 (13.6)0.20321.8 (13.7)0.146Yes30.6 (20.8)31.5 (20.8)Renal replacement therapyNo21.3 (13.4)0.13221.4 (13.4)0.170Yes22.7 (14.3)22.7 (14.4)ICU stay duration0.2310.0010.2190.132\*scores ranging from 0 to 100; the higher the score, the higher the discomfortSAPS II Simplified Acute Physiology Score II (range from 0 to 156, with higher scores indicating more severe illness)

Discussion {#Sec11}
==========

The initial version of IPREA was developed and validated from a large sample of unselected ICU patients by a working group that include ICU physicians, ICU nurses, and experts on patient-reported outcomes assessment. Use of IPREA in the clinical routine highlighted the absence from the assessment of two significant discomforts: feeling depressed and shortness of breath occurring during the ICU stay. These two items were added to this initial version, leading to a total of 18 items. In this study, we reported the validation of the 18-item version of IPREA.

Concerning the psychometric properties, the 18-item version met standards and showed equivalent metric properties in comparison with the 16-item version that could raise questions about the utility of a longer version. The addition of two items did not modify the unidimensional structure of the tool supported by component factor analyses and Rasch analysis. The pattern of item goodness-of-fit confirmed that all the items measure the same concept. The overall score probably reflected quite a broad range of patient experience (favorable and unfavorable) and may have failed to identify some significant areas of patient distress; but item scores allowed a detailed description by type of discomfort.

However, we showed that these two additional items in the IPREA questionnaire, shortness of breath and feeling depressed, will be very useful for future studies, as well as to test the efficacy of programs regarding the eventual association between the self-reported score of feeling of depressed on the day of ICU discharge and the prevalence of severe symptoms of depression in survivors of critical illness, as measured, for example with specific tools such as the Hospital and Anxiety Depression scale several months after ICU discharge.

As with the 16-item version, the 18-item version of IPREA showed high floor effects leading to a low potential discriminative power or a difficulty in bringing out differences between groups, for example. However, this observation is usual in "satisfaction-like" tools, due to the undesirable nature of the measured trait. Perception of a discomfort may be considered an undesirable perception.

The question of completion by the bedside nurses is legitimate. In the future, the patients could directly report their scores on a digital platform. However, this suggestion is not easy in real life. On the day of ICU discharge, most of patients are not well enough to be able to optimally use an electronic device. To be used in a pragmatic clinical routine, we think that relying on nurses remains appropriate. The method of data collection employed, in which patients completed the questionnaire just before being discharged, may have over- or under estimated the level of discomfort compared to questionnaires completed at home. Future studies should be conducted based on external observers and repeated administration of the IPREA after ICU discharge. The reproducibility of the 18-item version should be assessed in future studies.

The scores of perceived ICU-related discomforts are rather low. This phenomenon could be partially explained by the Hawthorne effect \[[@CR27], [@CR28]\], i.e., more efforts were made by the medical staff to reduce potential sources of discomfort because they knew that they were observed.

The question of the importance of the effect should be examined through future studies by the determination of the minimal clinically important difference in the IPREA score(s) \[[@CR29]\].

Finally, International collaborations should be planned in the future to perform linguistic validation process. Providing multiple language versions of a questionnaire allows researchers to pool data from different countries in multinational studies, to compare scores between countries and to establish norms.

Conclusion {#Sec12}
==========

The 18-item version of IPREA is easy to use and possesses satisfactory psychometric properties. The availability of a reliable and valid French questionnaire concerning self-perceived patient discomforts during an ICU stay enables feedback from patients and health care teams to be incorporated in a continuous quality health care improvement strategy. The use of the 18-item version of IPREA in comparison with the 16-item version should be recommended because of its potential to improve tailored programs for reducing two self-perceived discomforts, frequently reported by patients and acknowledged by healthcare teams in the ICU, shortness of breath and feeling depressed.

CFA

:   Confirmatory factor analysis

CFI

:   Comparative fit index

ICU

:   Intensive care unit

INFIT

:   Item goodness-of-fit statistics

IPREA

:   Inconforts des patients de reanimation

MV

:   Mechanical ventilation

NIV

:   Non Invasive ventilation

RMSEA

:   Root mean square error of approximation

RRT

:   Renal replacement therapy

SAPS II

:   Simplified acute physiology score

TMCP

:   Tailored multicomponent program

We thank all the nursing staff members and doctors whose enthusiasm and work have made this clinical trial possible. We particularly thank Anderson Loundou (Unité de recherche EA3279, Aix-Marseille Université) for participating in the statistical analysis; Bénédicte Mauchien (CH de Chartres) for her major and invaluable role in providing technical and educational support to all the investigators under the supervision of the lead investigator.

We thank all the members of the IPREA Study group as co-investigators and collaborators (iprea.group\@gmail.com).

Members of the IPREA study group

Co-investigators and collaborators (alphabetically by institution, all in France) from Centre Hospitalier (CH) d'Auxerre: Karine Vie; Centre Hospitalier (CHU) de Brest: Gwenaëlle Lannuzel; CHU Beaujon, Assistance Publique-Hôpitaux de Paris (AP-HP): Hélène Bout; CHU Dijon Bourgogne: Jean-Philippe Parthiot, Isabelle Chazal, Philippe Charve, Caroline Prum, Jean-Pierre Quenot, Nora Perrot, Francis Augier, Niloufar Behechti, Claudine Cocusse, Céline Foulon, Laurence Goncalves, Abdesselem Hanchi, Etienne Legros, Ana Isabel Mercier, Nicolas Meunier-Beillard, Nathalie Nuzillat, and Alicia Richard; CH de Douai: Claire Boulle, Benjamin Kowalski, and Elisa Klusek; CHU Raymond Poincaré, AP-HP: Tarek Sharshar, Andrea Polito, Caroline Duvallet, and Sonia Krim; Groupe Hospitalier de La Rochelle-Ré-Aunis: Nicolas Girard; CH de Chartres: Juliette Audibert-Souhaid, Cécile Jourdain, and Stéphane Techer; CH Emile Roux, Le Puy-en-Velay: Corinne Chauvel, and Corinne Bruchet; CH de Lens: Johanna Temime, Stéphanie Beaussart, and Fabienne Jarosz; CHU Edouard Herriot, Hospices Civils de Lyon: Julien Crozon-Clauzel, Serge Olousouzian, Sylvie Pereira, Loïc Argentin, and Valérie Cerro; Hôpital Européen de Marseille: Déborah Levy; CHU Hôpital Nord, Assistance Publique Hôpitaux de Marseille: Sébastien Andre, Christophe Guervilly, Laurent Papazian, and Myriam Moussa; Clinique Ambroise Paré, Neuilly/Seine: Stéphanie Renoult, Delphine Biet, and Steve Novak; CHU Nice: Jean-Christophe Orban, Aminata Diop, and Carole Ichai; CHU Cochin, AP-HP: Antoine Tesniere, Jean-Pascal Goupil, and Frédérique Laville; CHU Hôpital Européen Georges Pompidou, AP-HP: Nadège Rutter; Groupe Hospitalier Paris Saint-Joseph: Sandie Brochon, and Kelly Tiercelet; CHU Pitié-Salpêtrière, AP-HP: Julien Amour, Nora Ait-Hamou, and Marjorie Leger; CHU Saint-Louis, AP-HP: Virginie Souppart; CHU La Milétrie, Poitiers: Emilie Griffault, Marie-Line Debarre, Céline Deletage, Anne-Laure Guerin, Carole Guignon, and Sabrina Seguin; CH Victor Provo, Roubaix: Christophe Hart, and Kathy Dernivoix; CHU Strasbourg: Caroline Wuiot, Karine Sanches, and Stéphane Hecketsweiler; Centre Hospitalier Intercommunal Toulon/La Seyne sur mer: Catherine Sylvestre-Marconville and Vincent Gardan; and CH de Troyes: Stéphanie Deparis-Dusautois and Yana Chaban.

Funding {#FPar1}
=======

This research was financially supported by a grant from the Programme Hospitalier de Recherche Clinique National, 2012, 12--010-0554, funded by the French Ministry of Health.

Availability of data and materials {#FPar2}
==================================

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Conception and design: PA, PK. Study coordination: PK. Acquisition of data: PK, PE, MAG, AB, GS, BF, TS, MF, MN, AS, MV, RR, AF, JA, AR, MGO, PC, QL, IV, DT, JP, RGP, NR, CV, EA, OM. Analysis of data: KB, MB. Interpretation of data: KB, MB, PK, PA. Drafting and writing of manuscript: KB, MB, PA, PK. All authors read and approved the final manuscript.

Ethics approval and consent to participate {#FPar3}
==========================================

Regulatory monitoring has been performed in accordance with the French law needing the approval of the French ethics committee (Comité de Protection des Personnes Tours Région Centre-Ouest 1, 28/08/2013, reference number 2013-S10). All records and subjects' identity remained confidential in accordance with the French regulations: the French National Committee of Informatics and Liberties (Commission nationale de l'informatique et des libertés, 20/03/2014, reference number DR-2014-097) and the French Consultative Committee for the data processing in health research (Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé, 12/12/2013, reference number 13.642bis). Consent has been obtained from each participant.

Consent for publication {#FPar4}
=======================

Not applicable.

Competing interests {#FPar5}
===================

Dr. Kalfon received consulting fees from Philips Healthcare. On behalf of all remaining authors, the corresponding author states that the remaining authors have no conflict of interest. The other authors have stated that they had no interests which might be perceived as posing a conflict or bias.

Publisher's Note {#FPar6}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
